The European VAX4ASF project will study next-generation vaccines against ASF
Backed by Horizon Europe and led by HIPRA, the 4-year project bets on the potential of live attenuated vaccines to develop an effective, enduring, and secure solution against ASF virus, contributing to animal welfare, global economic stability, and rural communities.